Miroslava P.
- Country
- Czechia
- Department
- NA
Research Overview
- Evaluation of Balcinrenone and Dapagliflozin on Cardiovascular Outcomes in Heart Failure Patients with Renal Impairment: A Phase III Randomized, Double-Blind Study
- Efficacy, Safety, and Tolerability of JTT-861 in Heart Failure with Reduced Ejection Fraction: A Phase 2a Randomized, Double-blind, Placebo-controlled Study
- Evaluation of Olpasiran in Reducing First Major Cardiovascular Events in Patients with Elevated Lipoprotein(a) Levels: A Double-Blind, Randomized, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 67 of 495 partner sites.
Specializations
Cardiovascular Research
The investigator specializes in treating patients with heart failure, particularly focusing on cases with reduced ejection fraction (HFrEF). Their research encompasses innovative therapeutic approaches for managing complex cardiac conditions.
- Heart Failure Management
- Cardiac Function Assessment
- Cardiovascular Therapeutics
Primary focus includes evaluating novel treatment options for patients with compromised cardiac function.
Renal Medicine
Expertise extends to the treatment of patients with comorbid kidney impairment, particularly in conjunction with cardiac conditions. The investigator studies the intersection of renal and cardiovascular health.
- Kidney Function Assessment
- Cardiorenal Syndrome
- Renal Complications
Special interest in therapeutic approaches addressing both cardiac and renal complications simultaneously.
Therapeutic Innovation
The investigator evaluates novel therapeutic compounds and combination treatments for cardiovascular conditions. Their work includes assessment of drug efficacy and safety in complex patient populations.
- Drug Safety Evaluation
- Treatment Optimization
- Clinical Outcomes Assessment
Focuses on developing improved treatment strategies for patients with multiple cardiovascular comorbidities.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.